Vaccine against Jembrana Disease Virus Infection: A Summary Findings
Asmarani Kusumawati, Tenri Ashari Wanahari, Pudji Astuti, Kurniasih, Basofi Ashari Mappakaya and Hastari Wuryastuty
DOI : 10.3844/ajisp.2015.68.73
American Journal of Immunology
Volume 11, 2015
Jembrana disease constitutes the main concern in cattle industry especially in Indonesia and Australia as it has caused important economic losses due to mortality of cattle. The pathology of the disease is unusual for a lentivirus infection as it is associated with a severe, often lethal disease syndrome and a short incubation period in cattle. For lack of efficient medical treatment of JDV-infected cattle, vaccination may therefore constitute an effective measure for the prevention or eradication of Jembrana disease. Up to date, only one type of vaccine has been reported and tested. It is based on inactivated, tissue-derived virus antigens (Tabanan/87 isolate, JDVTAB/87). This review summarize show current Jembrana disease vaccine was developed as well as evaluated and how these information might be useful in future vaccine design.
© 2015 Asmarani Kusumawati, Tenri Ashari Wanahari, Pudji Astuti, Kurniasih, Basofi Ashari Mappakaya and Hastari Wuryastuty. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.